Open label phase III study of arfolitixorin vs leucovorin in mFOLFOX-6 for first-line treatment of metastatic colorectal cancer: AGENT

Tabernero, J; Prager, G; Stintzing, S; Lenz, HJ; Nygren, HP; Papadimitriou, C

ANNALS OF ONCOLOGY, 2019; 30 ():

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索